HMGCS2 and metabolic dysfunction-associated steatotic liver disease: These findings suggest that insulin resistance contributes to ketogenic dysfunction in NAFLD, yet HMGCS2 expression has not been causally linked to reduced ketogenesis in patients with NAFLD.